Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium Article

Kuo, DYS, Timmins, P, Blank, SV et al. (2006). Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: A brief communication from the New York Phase II consortium . GYNECOLOGIC ONCOLOGY, 100(1), 160-165. 10.1016/j.ygyno.2005.08.033

cited authors

  • Kuo, DYS; Timmins, P; Blank, SV; Fields, AL; Goldberg, GL; Murgo, A; Christos, P; Wadler, S; Runowicz, CD

sustainable development goals

authors

publication date

  • January 1, 2006

webpage

published in

keywords

  • CHEMOTHERAPY
  • CISPLATIN
  • ETOPOSIDE
  • IFOSFAMIDE
  • LEIOMYOSARCOMA
  • Life Sciences & Biomedicine
  • MESNA
  • MIXED MESODERMAL TUMORS
  • ONCOLOGY-GROUP
  • Obstetrics & Gynecology
  • Oncology
  • Science & Technology
  • UTERINE SARCOMA
  • UTERUS
  • advanced disease
  • gynecologic sarcoma
  • recurrence
  • thalidomide

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 160

end page

  • 165

volume

  • 100

issue

  • 1